PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.
PHARMASEAL was born in 2016 with the mission to create a digital platform that enables their customers to increase control of their clinical trials and accelerate product development.PHARMASEAL is developing the first B2B control platform for biopharmaceutical companies to manage their enterprise clinical trials.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 3, 2019 | Series A | £1M | 1 | — | — | Detail |
Jan 23, 2018 | Seed | £500K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Mercia Fund Managers | — | Series A |